Esophageal stenting in palliative care for advanced cancer

For people with advanced oesophageal or gastro-oesophageal cancer, swallowing can become difficult, painful and frightening. An expandable metal stent can reopen the narrowed passage, allowing fluids and soft food to reach the stomach with less effort. Its purpose is usually comfort and function rather than tumour removal.

This is especially relevant when disease is too extensive for curative surgery, chemotherapy or radiotherapy, or when treatment is unlikely to improve swallowing quickly enough. Palliative care focuses on quality of life, symptom relief and personal priorities, with stenting considered alongside radiotherapy, systemic treatment, nutritional support and end-of-life care.

In Australia, decisions may involve a multidisciplinary team at a metropolitan centre such as Royal Prince Alfred Hospital in Sydney, The Alfred in Melbourne or a regional service supporting patients in places such as Townsville or Alice Springs. Travel distance, access to therapeutic endoscopy and the availability of home nursing can influence how quickly a procedure is arranged.

The strongest plan is individualised. A person who wants to keep enjoying small meals may value rapid relief from obstruction, while someone nearing the end of life may prefer medication-based comfort care and avoid hospital procedures. Clear discussions with the patient, family, gastroenterologist, oncologist and palliative care team are essential.

How a stent relieves malignant obstruction

An oesophageal stent is a flexible mesh tube placed across the tumour-related narrowing. Once released, it expands against the oesophageal wall and creates a channel for saliva, liquids and food. Many patients notice improved swallowing within hours or a few days, although the result depends on the tumour’s position, length and degree of obstruction.

Stenting may also help when a tumour causes a gastro-oesophageal junction blockage or, less commonly, an abnormal connection between the oesophagus and airway. Modern fully or partially covered devices are selected according to anatomy and the likelihood of migration. Imaging and endoscopic assessment help clinicians plan the safest position.

The aim is symptom control, not cure. A stent does not remove cancer and cannot prevent disease progression elsewhere. It can, however, reduce repeated emergency presentations for dehydration, aspiration risk or inability to swallow essential medicines.

Selecting the right patient and timing

Assessment usually includes endoscopy, contrast imaging and a review of the person’s overall condition. Clinicians consider expected survival, nutritional status, respiratory health, tumour location, previous radiotherapy and whether a stent could interfere with later treatment. If a patient is able to swallow adequately, immediate stenting may offer little benefit.

For some patients, radiotherapy or chemotherapy can provide longer-term control of dysphagia, though these treatments may take time to work. Stenting is often favoured when swallowing must improve promptly, when cancer is progressing despite treatment, or when life expectancy is limited and a short hospital stay is the priority.

A decision may be particularly complex after previous endoscopic treatment. Discussions of early neoplasia treatment help distinguish superficial disease suitable for endoscopic mucosal resection from advanced obstruction requiring palliative strategies.

Benefits, risks and aftercare

The main benefit is fast improvement in dysphagia. Better oral intake can support medication administration, social meals and personal independence, even when nutritional recovery is modest. Some patients still need high-calorie drinks, dietetic advice or a feeding tube, especially if the cancer causes fatigue or severe weight loss.

Common early effects include chest discomfort, reflux and a sensation of pressure as the stent expands. Later complications can include migration, tumour ingrowth, bleeding, perforation and recurrent blockage. Reflux is more likely when the stent crosses the lower oesophageal sphincter, so positioning, medication and eating habits matter.

Warning signs requiring prompt review

• New or worsening chest pain
• Fever, breathlessness or sudden coughing during swallowing
• Inability to swallow fluids
• Vomiting blood or black stools

Patients are often advised to sit upright while eating, take small bites and chew thoroughly. A soft diet may be recommended initially, followed by gradual progression according to tolerance. In Australia, discharge planning should include clear after-hours contacts because patients may live several hours from the treating hospital.

Coordinating nutrition and palliative support

A dietitian can help maintain energy intake without making meals exhausting. Smooth foods, minced meals, nourishing soups and oral supplements may be easier than dry meat, bread or fibrous vegetables. Care should be taken with food textures that can lodge above or within the stent.

Palliative care involvement does not mean that active cancer treatment has stopped. The team can manage pain, nausea, reflux, anxiety, constipation and breathlessness while coordinating with oncology and endoscopy. Australian public hospitals may provide specialist palliative care, while private services, general practitioners and community nurses often support care at home.

Practical support for families

• Keep a written list of medicines and swallowing changes
• Record which foods and fluids are tolerated
• Arrange transport and a local emergency plan
• Discuss preferred place of care early

Family members may need guidance on safe feeding and on recognising distress. Conversations should address whether future stent procedures, hospital admissions or artificial nutrition fit the person’s goals, rather than assuming that every available intervention should be pursued.

Making a goal-based treatment decision

Stenting is most useful when the expected improvement in swallowing outweighs procedural burden and complication risk. The conversation should cover what the person hopes to regain, how quickly relief is needed, and whether the likely benefit will last long enough to matter. Some people prioritise eating and attending family gatherings; others place greater value on staying at home without invasive treatment.

Clinical teams also weigh local resources. A patient in regional New South Wales may need transfer to a tertiary endoscopy unit, while someone in Melbourne or Brisbane may have faster access to specialist review. Travel, accommodation, carer availability and follow-up arrangements are practical parts of the medical decision.

The next step is a multidisciplinary review that documents swallowing severity, cancer status, treatment goals and a clear plan for managing complications.